FDA Inspection
Northampton Hospital Corporation d.b.a. Easton HospitalNorthampton Hospital Corporation d.b.a. Easton Hospital – FDA Inspection, Feb 4, 2016
Record Details
This FDA Inspection record concerns Northampton Hospital Corporation d.b.a. Easton Hospital, with an inspection on February 4, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 4, 2016
- Product Type
- Drugs
View Company Profile
ID · ba010b57-7a26-4c2e-bb79-3a6fd9cca0c6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 957595
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
6- 21 CFR 56.115(a)(5)List of members
- 21 CFR 56.115(a)(4)Copies of IRB/CI correspondence
- 21 CFR 56.115(a)(3)Records of continuing review
- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.108(b)(3)Reporting of suspension/termination
- 21 CFR 56.110(c)Method to keep members advised
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Northampton Hospital Corporation d.b.a. Easton Hospital
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 30, 2014 | OAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Northampton Hospital Corporation d.b.a. Easton Hospital
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.